Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Miroslav Lorenc is active.

Publication


Featured researches published by Miroslav Lorenc.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2001

The changes of biological markers and treatment efficacy in schizophrenia

Eva Češková; Pavel Drybčák; Petr Hrobař; Miroslav Lorenc; Hana Procházková; Josef Špaček

1. In a group of schizophrenic patients, the effect and selected parameters of biological markers were evaluated during the index hospitalisation in the acute phase of schizophrenia (n = 30) and then after one year of ambulatory treatment. 2. During the acute treatment, a significant drop in symptomatology was recorded in average; an analogical tendency was observed further on, too. Apart from that, a significant change was observed in 5/41 parameters being monitored (the pair t-test): I) decrease in the total NES score, II) decrease in the sensorial integration subscale NES score, III) increase in psychomotor speed, IV) decrease in auditory reaction time, V) increase in basal cortisol. 3. In the comparison of the successfully (severity of illness after one year = 1, 2) and unsuccessfully (severity of illness after one year > or =3) treated patients in the beginning of treatment in the acute phase, the unsuccessful group had a significantly higher score of negative symptomatology, and by the end of the acute treatment, again, a significantly higher score of negative symptomatology, a higher total PANSS score and a greater severity of illness. 4. In the acute phase, the successful group had a significantly better score in individual items of the Contemporary Memory Scale and a significantly worse performance and goal-aimed concentration in the Bourdon test than the unsuccessfully treated one; apart from that, it had a significantly higher cortisol level after dexamethasone, which was also reflected in the lower percentage rate of dexamethasone nonsupression. 5. In the course of the year, a drop in the total NES score for the individual subscales occurred; a significant drop was observed in the sensory integration subscale. The worse concentration items improved significantly in the successful group in contrast to the unsuccessful group, where they showed a downgrade tendency. Changes in Contemporary Memory Scale were negligible and mostly below statistical significance. Apart from that, a drop in basal cortisolemia occurred in the successful group and an increase in cortisolemia after administering dexamethasone was registered in the unsuccessful group. 6. The more successful group had a significantly lower NES score, a significantly better visual reaction time and a smaller forgetting item (in percentiles) after the one-year period.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2002

Biological markers and possibilities for predicting therapeutic results in schizophrenia: A methodological contribution

Eva Češková; Pavel Drybčák; Miroslav Lorenc


Homeostasis | 1998

BIOLOGICAL MARKERS AND LONGTERM PREDICTION OF SCHIZOPHRENIA

Eva Češková; Miroslav Lorenc; Pavel Drybčák


European Neuropsychopharmacology | 1997

P.2.108 Prediction of acute treatment efficacy in schizophrenic disorder

Eva Češková; Miroslav Lorenc; Pavel Drybčák


Psychiatrie | 2001

Možnosti ovlivnění kognitivních funkcí risperidonem /Abstrakt/

Eva Češková; Josef Špaček; Marta Ondrušová; Miroslav Lorenc; Pavel Drybčák


Archive | 2001

The changes of biological markers and treatment efficacy inschizophrenia/Abstract/

Eva Češková; Pavel Drybčák; Petr Hrobař; Miroslav Lorenc; Hana Procházková; Josef Špaček


Archive | 2000

Prolactemia and risperidone/Abstract/

Eva Češková; Pavel Drybčák; Miroslav Lorenc; Marta Ondrušová


Archive | 2000

Structual changes in first-episode schizophrenia

Eva Češková; Boleslav Prokeš; Miroslav Lorenc; Pavel Drybčák; Marta Ondrušová


Archive | 2000

Nukleární magnetická rezonance u prvních atakschizofrenie./Abstrakta/

Eva Češková; Boleslav Prokeš; Marta Ondrušová; Miroslav Lorenc; Pavel Drybčák


Archive | 2000

Size of hippocampus in first-episode schizophrenia /Abstract/

Eva Češková; Bolelslav Prokeš; Marta Ondrušová; Josef Špaček; Miroslav Lorenc; Pavel Drybčák

Collaboration


Dive into the Miroslav Lorenc's collaboration.

Top Co-Authors

Avatar

Eva Češková

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge